A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

Ian W. Flinn, Nancy L. Bartlett, Kristie A. Blum, Kirit M. Ardeshna, Ann S. Lacasce, Christopher R. Flowers, Andrei R. Shustov, Kenneth S. Thress, Patrick Mitchell, Fred Zheng, Jeffrey M. Skolnik, Jonathan W. Friedberg

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)'. Together they form a unique fingerprint.

Medicine & Life Sciences